NeuroTherm buys S&N interventional spine pain management biz
This article was originally published in The Gray Sheet
Executive Summary
NeuroTherm acquires Smith & Nephew's interventional spine pain management business, the firm announces April 7. The deal will "go a long way towards sustaining NeuroTherm's leading position in the interventional pain space," an estimated $5 billion global market, according to CEO Larry Hicks. Headquartered in Wilmington, Mass., NeuroTherm gains S&N's CDS Discography System, Spinecath and Acutherm catheters, and a line of radiofrequency devices. It also will be a distributor of the Trucath injection system. NeuroTherm's existing lineup includes RF devices and catheters for pain. The acquired product line "is highly complementary," the firm notes